نتایج جستجو برای: myeloablative conditioning

تعداد نتایج: 48131  

Journal: :international journal of hematology-oncology and stem cell research 0
kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohammad jahani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran seyyedasadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran babak bahar hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran masoud iravani hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran roshanak derakhshandeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

introduction: allogeneic hematopoietic stem cell transplantation (hsct) has been reported to be a successful curative treatment in aml patients. myeloablative conditioning (mac) is used more frequent as a preparing regimen. this study attempts to compare the outcome of patients who has received mac and reduced- intensity conditioning (ric). methods: totally, 618 patients with aml underwent hsct...

2007
Inho Kim Kyung-Hun Lee Yunhee Choi Bhumsuk Keam Nam Hee Koo Sung-Soo Yoon Keun-Young Yoo Seonyang Park Byoung Kook Kim

We compared the outcomes of allogeneic hematopoietic stem cell transplantation using reduced intensity and myeloablative conditioning for the treatment of patients with advanced hematological malignancies. A total of 75 adult patients received transplants from human leukocyte antigen-matched donors, coupled with either reduced intensity (n=40; fludarabine/melphalan, 28; fludarabine/cyclophospha...

Journal: :Haematologica 2016
Bipin N Savani Myriam Labopin Nicolaus Kröger Jürgen Finke Gerhard Ehninger Dietger Niederwieser Rainer Schwerdtfeger Donald Bunjes Bertram Glass Gerard Socié Per Ljungman Charles Craddock Frédéric Baron Fabio Ciceri Norbert Claude Gorin Jordi Esteve Christoph Schmid Sebastian Giebel Mohamad Mohty Arnon Nagler

The outcome of patients undergoing HLA-matched unrelated donor allogeneic hematopoietic cell transplantation following reduced-intensity conditioning or myeloablative regimens is reported to be equivalent; however, it is not known if the intensity of the conditioning impacts outcomes after mismatched unrelated donor transplantation for acute myeloid leukemia. Eight hundred and eighty three pati...

2004
Kanchan Rao Persis J Amrolia Alison Jones Catherine M Cale Paru Naik Doug King Graham E Davies H. Bobby Gaspar Paul A Veys

The optimal approach to stem cell transplantation in children with immunodeficiency who lack a matched family donor is controversial. Unrelated donor stem cell transplant gives equivalent outcome to mismatched family donor stem cell transplant in Severe combined immunodeficiency whereas unrelated donors may be preferable in nonSevere combined immunodeficiency children. However, unrelated donor ...

Journal: :Blood 2005
Kanchan Rao Persis J Amrolia Alison Jones Catherine M Cale Paru Naik Doug King Graham E Davies H Bobby Gaspar Paul A Veys

The optimal approach to stem cell transplantation in children with immunodeficiency who lack a matched family donor is controversial. Unrelated donor stem cell transplantation gives equivalent outcome to mismatched family donor stem cell transplantation in severe combined immunodeficiency, whereas unrelated donors may be preferable in non-severe combined immunodeficiency children. However, unre...

2013
Kia J. Langford-Smith Zara Sandiford Alex Langford-Smith Fiona L. Wilkinson Simon A. Jones J. Ed Wraith Robert F. Wynn Brian W. Bigger

Non-myeloablative allogeneic haematopoietic stem cell transplantation (HSCT) is rarely achievable clinically, except where donor cells have selective advantages. Murine non-myeloablative conditioning regimens have limited clinical success, partly through use of clinically unachievable cell doses or strain combinations permitting allograft acceptance using immunosuppression alone. We found that ...

Journal: :Haematologica 2010
Stella Santarone Andrea Bacigalupo Antonio M Risitano Elena Tagliaferri Erminia Di Bartolomeo Anna Paola Iori Alessandro Rambaldi Emanuele Angelucci Alessandra Spagnoli Federico Papineschi Stefania Tamiazzo Marta Di Nicola Paolo Di Bartolomeo

BACKGROUND Paroxysmal nocturnal hemoglobinuria is an acquired clonal disorder of the hemopoietic stem cells for which the only curative treatment is allogeneic hematopoietic stem cell transplantation. DESIGN AND METHODS The aim of this retrospective study was to assess the long-term clinical and hematologic results in 26 paroxysmal nocturnal hemoglobinuria patients who received hematopoietic ...

Journal: :Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009
Ghada I Mossallam Azza M Kamel Barry Storer Paul J Martin

The utility of routine chimerism analysis as a prognostic indicator of subsequent outcomes after allogeneic hematopoietic cell transplantation (HCT) with myeloablative conditioning regimens remains controversial. To address this controversy, routine chimerism test results at 2 to 6 months after HCT with myeloablative conditioning regimens were evaluated for association with subsequent risk of c...

2008
Hyoung Jin Kang Hee Young Shin Sun Hie Ko Jeong Ah Park Eun Kyung Kim Jung Woo Rhim Joong Gon Kim Hyo Seop Ahn

Wiskott-Aldrich syndrome (WAS) is an X-linked congenital immune-deficiency syndrome, and bone marrow transplantation (BMT) has become a curative modality. However, the transplant with the alternative donor needed more intensive conditioning with increased treatment-related toxicities. Recently, fludarabine-based reduced toxicity myeloablative conditioning regimens have been developed for adult ...

Journal: :Blood 2001
C D Bolan S F Leitman L M Griffith R A Wesley J L Procter D F Stroncek A J Barrett R W Childs

Delayed donor red cell engraftment and pure red cell aplasia (PRCA) are well-recognized complications of major ABO-incompatible hematopoietic stem cell transplantation (SCT) performed by means of myeloablative conditioning. To evaluate these events following reduced-intensity nonmyeloablative SCT (NST), consecutive series of patients with major ABO incompatibility undergoing either NST (fludara...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید